BeStock  
Stocks › Biotechnology › VERA

Vera Therapeutics VERA

US equityMarket cap rank #2729Biotechnology
$25.45 −$1.30 (-4.86%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $24.88 -2.24%
Open$26.37
Prev close$26.75
Day range$25.16 – $27.15
Volume1.37M
Market cap$1.84B
P/E (TTM)–
Dividend yield–

VERA Stock News

Headlines matching Vera Therapeutics or the VERA ticker, most recent first.

  • Is NVIDIA (NVDA.US) facing renewed resistance as its stock price hits new highs? Amid surging demand for both GPUs and Vera CPUs, a director has cashed out $300 million in a major sell-off.Zhitong Finance · 23 Sep 2026 · Direct mention
  • NVIDIA's stock hits a new high but faces resistance again? As demand for GPUs and Vera CPUs surges on two fronts, a Director has cashed out $300 million. PositiveZhitong Finance · 23 Sep 2026 · Direct mention
  • Wedbush Maintains Vera Therapeutics(VERA.US) With Hold Rating, Maintains Target Price $34Market news · 16 Sep 2026 · Direct mention
  • A Quick Look at Today's Ratings for Vera Therapeutics(VERA.US), With a Forecast Between $34 to $90Market news · 16 Sep 2026 · Direct mention
  • TD Cowen Maintains Vera Therapeutics(VERA.US) With Buy Rating, Maintains Target Price $78Market news · 31 Aug 2026 · Direct mention
  • Takeda Pharmaceutical: Regarding the U.S. Food and Drug Administration (FDA) approval of MIMRYLO (rusfertide), which has the potential to usher in a paradigm shift in the treatment of polycythemia vera. PositiveJPX · 29 Aug 2026 · Direct mention
  • Takeda Pharmaceutical: Takeda Receives U.S. FDA Approval of MIMRYLO (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera PositiveJPX · 29 Aug 2026 · Direct mention
  • J.P. Morgan Maintains Vera Therapeutics(VERA.US) With Buy Rating, Cuts Target Price to $76 NegativeMarket news · 17 Aug 2026 · Direct mention
  • Wells Fargo Maintains Vera Therapeutics(VERA.US) With Buy Rating, Maintains Target Price $70Market news · 13 Aug 2026 · Direct mention
  • HC Wainwright & Co. Maintains Buy on Vera Therapeutics, Lowers Price Target to $90Benzinga · 12 Aug 2026 · Direct mention
  • H.C. Wainwright Maintains Vera Therapeutics(VERA.US) With Buy Rating, Cuts Target Price to $90 NegativeMarket news · 12 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Vera Therapeutics(VERA.US), With a Forecast Between $34 to $100Market news · 11 Aug 2026 · Direct mention
  • Wedbush Maintains Vera Therapeutics(VERA.US) With Hold Rating, Cuts Target Price to $43 NegativeMarket news · 13 Jul 2026 · Direct mention
  • LifeSci Capital Maintains Vera Therapeutics(VERA.US) With Buy Rating, Maintains Target Price $90Market news · 11 Jul 2026 · Direct mention
  • Evercore Maintains Vera Therapeutics(VERA.US) With Buy Rating, Maintains Target Price $91Market news · 10 Jul 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on VERA.

Sign in to join the discussion.

Scroll to Top